Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Market Research Future | PRODUCT CODE: 1340772

Cover Image

PUBLISHER: Market Research Future | PRODUCT CODE: 1340772

Mesotherapy Market Research Report Forecast to 2030

PUBLISHED:
PAGES: 128 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4950
PDF & Excel (Multi User License)
USD 5950
PDF & Excel (Enterprise License)
USD 7250

Add to Cart

Market Overview

Mesotherapy Market is projected to register a significant CAGR of 12.48% during the forecast period.

The variables adding to the development of the market are the rising predominance of skin issues and going bald and the developing reception of clinical the travel industry.

Mesotherapy is a method that utilizes infusions of chemicals, nutrients, proteins, and plant concentrates to lessen the overabundance of fat and revive the skin. Skin issues, for example, skin inflammation turn out to be more normal due to heredity, meds, smoking, and nicotine.

Furthermore, many non-industrial countries have as of late fabricated state-of-the-art clinical offices and given medical care administrations for a portion of the cost of created countries. Perhaps of the most well-known method in the clinical, the travel industry area is a restorative medical procedure. Most superficial medical procedures are self-financed, so this area of the worldwide clinical travel industry market has become progressively determined by the surface level a medical procedure. Clinical travel industry areas have a sizable number of corrective medical procedure offices. Subsequently, rising rates of balding and skin issues and the developing reception of clinical the travel industry is moving the market development.

Market Segmentation

The Mesotherapy Market has been divided into various product categories, including mesotherapy solutions, masks, lotions, gadgets, and others.

Based on application the market is divided into fat loss, hair loss, stretch marks, anti-aging, face rejuvenation, acne & scar treatment, and others. The Mesotherapy Market has been divided into hospitals, dermatological clinics, and other entities based on end users.

Regional Insights

North America represented the biggest market portion of 36.31% in 2022 attributable to the high ubiquity of corrective methodology, for example, mesotherapy and the presence of countless restorative specialists in the region. According to the Global Society of Tasteful Plastic Medical procedure (ISAPS), in 2020, there were about more than 7,000 rehearsing plastic specialists in the US.

Europe is expected to observe critical development during the estimated time frame because of a bigger number of patients, the rising concern in regard to tasteful appearance, and the presence of key organizations in the region. According to the Worldwide Society of Tasteful Plastic Medical Procedure (ISAPS), Germany, and Italy represented the most elevated non-surgeries in the region in 2020. Moreover, the Germany mesotherapy market held the biggest market share in 2022 and is the quickest-developing market in the Europe region.

Asia-Pacific is expected to enroll the most noteworthy development rate over the conjecture period. This is because of variables like further developing medical services foundation, developing venture by key part with neighborhood producers, expanding restorative uses, and developing interest for tasteful techniques inside the region.

Major Players

Key Companies in the Mesotherapy Market include FILORGA (France), Koru Pharmaceuticals Co., LTD. (South Korea), Fusion Meso (Spain), Mesoskinline (Denmark), Toskani Cosmetics (Spain), AbbVie Inc. (US), Dermoaroma (Italy), Galderma Laboratories, L.P. (Switzerland), Messoessence (Spain), and Institute BCN (Spain).

Product Code: MRFR/HC/10353-CR

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 LIST OF ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING
  • 3.2 SECONDARY RESEARCH
  • 3.3 PRIMARY RESEARCH
    • 3.3.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
    • 3.3.2 BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.4 FORECASTING TECHNIQUES
  • 3.5 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 3.5.1 BOTTOM-UP APPROACH
    • 3.5.2 TOP-DOWN APPROACH
  • 3.6 DATA TRIANGULATION
  • 3.7 VALIDATION

4 MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 INCREASING PREVELANCE OF SKIN PROBLEMS AND HAIR LOSS
    • 4.2.2 GROWING ADOPTION OF MEDICAL TOURISM
    • 4.2.3 DRIVERS IMPACT ANALYSIS
  • 4.3 RESTRAINTS
    • 4.3.1 SIDE EFFECTS ASSOCIATED WITH THE THERAPY
    • 4.3.2 RESTRAINTS IMPACT ANALYSIS
  • 4.4 OPPORTUNITIES
    • 4.4.1 CHANGING LIFESTYLE AND INCREASING URBANIZATION

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 R&D
    • 5.1.2 MANUFACTURING
    • 5.1.3 DISTRIBUTION & SALES
    • 5.1.4 POST-SALES MONITORING
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 THREAT OF NEW ENTRANTS
    • 5.2.2 BARGAINING POWER OF SUPPLIERS
    • 5.2.3 THREAT OF SUBSTITUTES
    • 5.2.4 BARGAINING POWER OF BUYERS
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 IMPACT OF COVID-19 ON THE GLOBAL MESOTHERAPY MARKET
    • 5.3.1 IMPACT ON SUPPLY CHAIN
    • 5.3.2 IMPACT ON REGIONS
    • 5.3.3 IMPACT ON PROVIDERS

6 GLOBAL MESOTHERAPY MARKET, BY PRODUCT

  • 6.1 OVERVIEW
  • 6.2 MESOTHERAPY SOLUTIONS
  • 6.3 MESOTHERAPY MASKS
  • 6.4 MESOTHERAPY CREAMS
  • 6.5 MESOTHERAPY DEVICES
  • 6.6 OTHERS

7 GLOBAL MESOTHERAPY MARKET, BY APPLICATION

  • 7.1 OVERVIEW
  • 7.2 ANTI-AGING
  • 7.3 FACIAL REJUVENATION
  • 7.4 STRETCH MARKS
  • 7.5 ACNE & SCAR TREATMENT
  • 7.6 FAT LOSS
  • 7.7 HAIR LOSS
  • 7.8 OTHERS

8 GLOBAL MESOTHERAPY MARKET, BY END USER

  • 8.1 OVERVIEW
  • 8.2 HOSPITALS
  • 8.3 DERMATOLOGY CLINICS
  • 8.4 OTHERS

9 GLOBAL MESOTHERAPY MARKET, BY REGION

  • 9.1 OVERVIEW
  • 9.2 NORTH AMERICA
    • 9.2.1 US
    • 9.2.2 CANADA
  • 9.3 EUROPE
    • 9.3.1 GERMANY
    • 9.3.2 FRANCE
    • 9.3.3 UK
    • 9.3.4 ITALY
    • 9.3.5 SPAIN
    • 9.3.6 REST OF EUROPE
  • 9.4 ASIA-PACIFIC
    • 9.4.1 CHINA
    • 9.4.2 JAPAN
    • 9.4.3 INDIA
    • 9.4.4 SOUTH KOREA
    • 9.4.5 AUSTRALIA
    • 9.4.6 REST OF ASIA-PACIFIC
  • 9.5 REST OF THE WORLD
    • 9.5.1 MIDDLE EAST
    • 9.5.2 AFRICA
    • 9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 COMPETITIVE BENCHMARKING
  • 10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL MESOTHERAPY MARKET
  • 10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL MESOTHERAPY MARKET
  • 10.5 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 10.5.1 PRODUCT APPROVAL AND LAUNCH

11 COMPANY PROFILE

  • 11.1 FILORGA
    • 11.1.1 COMPANY OVERVIEW
    • 11.1.2 FINANCIAL OVERVIEW
    • 11.1.3 PRODUCTS OFFERED
    • 11.1.4 KEY DEVELOPMENTS
    • 11.1.5 SWOT ANALYSIS
    • 11.1.6 KEY STRATEGIES
  • 11.2 MESOSKINLINE
    • 11.2.1 COMPANY OVERVIEW
    • 11.2.2 FINANCIAL OVERVIEW
    • 11.2.3 PRODUCTS OFFERED
    • 11.2.4 KEY DEVELOPMENTS
    • 11.2.5 KEY STRATEGIES
  • 11.3 KORU PHARMACEUTICALS CO., LTD.
    • 11.3.1 COMPANY OVERVIEW
    • 11.3.2 FINANCIAL OVERVIEW
    • 11.3.3 PRODUCTS OFFERED
    • 11.3.4 KEY DEVELOPMENTS
    • 11.3.5 KEY STRATEGIES
  • 11.4 FUSION MESO
    • 11.4.1 COMPANY OVERVIEW
    • 11.4.2 FINANCIAL OVERVIEW
    • 11.4.3 PRODUCTS OFFERED
    • 11.4.4 KEY DEVELOPMENTS
    • 11.4.5 SWOT ANALYSIS
    • 11.4.6 KEY STRATEGIES
  • 11.5 TOSKANI COSMETICS
    • 11.5.1 COMPANY OVERVIEWS
    • 11.5.2 FINANCIAL OVERVIEW
    • 11.5.3 PRODUCTS OFFERED
    • 11.5.4 KEY DEVELOPMENTS
    • 11.5.5 KEY STRATEGIES
  • 11.6 ABBVIE INC.
    • 11.6.1 COMPANY OVERVIEW
    • 11.6.2 FINANCIAL OVERVIEW
    • 11.6.3 PRODUCTS OFFERED
    • 11.6.4 ABBVIE INC.: KEY DEVELOPMENTS
    • 11.6.5 SWOT ANALYSIS
    • 11.6.6 KEY STRATEGIES
  • 11.7 GALDERMA LABORATORIES, L.P
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 FINANCIAL OVERVIEW
    • 11.7.3 PRODUCTS OFFERED
    • 11.7.4 KEY DEVELOPMENTS
    • 11.7.5 SWOT ANALYSIS
    • 11.7.6 KEY STRATEGIES
  • 11.8 DERMOAROMA
    • 11.8.1 COMPANY OVERVIEW
    • 11.8.2 FINANCIAL OVERVIEW
    • 11.8.3 PRODUCTS OFFERED
    • 11.8.4 KEY DEVELOPMENTS
    • 11.8.5 SWOT ANALYSIS
    • 11.8.6 KEY STRATEGIES
  • 11.9 MESSOESSENCE
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 FINANCIAL OVERVIEW
    • 11.9.3 PRODUCTS OFFERED
    • 11.9.4 KEY DEVELOPMENTS
    • 11.9.5 KEY STRATEGIES
  • 11.10 INSTITUTE BCN
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 FINANCIAL OVERVIEW
    • 11.10.3 PRODUCTS OFFERED
    • 11.10.4 KEY DEVELOPMENTS
    • 11.10.5 KEY STRATEGIES

12 APPENDIX

  • 12.1 REFERENCES
  • 12.2 RELATED REPORTS
Product Code: MRFR/HC/10353-CR

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
  • TABLE 1 LIST OF MESOTHERAPY PROVIDERS BY REGION
  • TABLE 2 GLOBAL: MESOTHERAPY MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 3 GLOBAL: MESOTHERAPY MARKET, FOR MESOTHERAPY SOLUTIONS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 4 GLOBAL: MESOTHERAPY MARKET, FOR MESOTHERAPY MASKS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 5 GLOBAL: MESOTHERAPY MARKET, FOR MESOTHERAPY CREAMS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 6 GLOBAL: MESOTHERAPY MARKET, FOR MESOTHERAPY DEVICES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 7 GLOBAL: MESOTHERAPY MARKET, FOR OTHERS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 8 GLOBAL: MESOTHERAPY MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 9 GLOBAL: MESOTHERAPY MARKET, FOR ANTI-AGING, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 11 GLOBAL: MESOTHERAPY MARKET, FOR FACIAL REJUVENATION, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 12 GLOBAL: MESOTHERAPY MARKET, FOR ACNE & SCAR TREATMENT, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 13 GLOBAL: MESOTHERAPY MARKET, FOR FAT LOSS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 14 GLOBAL: MESOTHERAPY MARKET, FOR HAIR LOSS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 15 GLOBAL: MESOTHERAPY MARKET, FOR OTHERS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 16 GLOBAL: MESOTHERAPY MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 17 GLOBAL: MESOTHERAPY MARKET, FOR HOSPITALS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 18 GLOBAL: MESOTHERAPY MARKET, FOR DERMATOLOGY CLINICS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 19 GLOBAL: MESOTHERAPY MARKET, FOR OTHERS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 20 GLOBAL: MESOTHERAPY MARKET, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 21 GLOBAL: MESOTHERAPY MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 22 GLOBAL: MESOTHERAPY MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 23 GLOBAL: MESOTHERAPY MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 24 NORTH AMERICA: MESOTHERAPY MARKET, BY COUNTRY, 2019-2030 (USD MILLION)
  • TABLE 25 NORTH AMERICA: MESOTHERAPY MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 26 NORTH AMERICA: MESOTHERAPY MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 27 NORTH AMERICA: MESOTHERAPY MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 28 US: MESOTHERAPY MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 29 US: MESOTHERAPY MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 30 US: MESOTHERAPY MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 31 CANADA: MESOTHERAPY MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 32 CANADA: MESOTHERAPY MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 33 CANADA: MESOTHERAPY MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 34 EUROPE: MESOTHERAPY MARKET, BY COUNTRY, 2019-2030 (USD MILLION)
  • TABLE 35 EUROPE: MESOTHERAPY MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 36 EUROPE: MESOTHERAPY MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 37 EUROPE: MESOTHERAPY MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 38 GERMANY: MESOTHERAPY MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 39 GERMANY: MESOTHERAPY MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 40 GERMANY: MESOTHERAPY MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 41 FRANCE: MESOTHERAPY MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 42 FRANCE: MESOTHERAPY MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 43 FRANCE: MESOTHERAPY MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 44 UK: MESOTHERAPY MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 45 UK: MESOTHERAPY MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 46 UK: MESOTHERAPY MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 47 ITALY: MESOTHERAPY MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 48 ITALY: MESOTHERAPY MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 49 ITALY: MESOTHERAPY MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 50 SPAIN: MESOTHERAPY MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 51 SPAIN: MESOTHERAPY MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 52 SPAIN: MESOTHERAPY MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 53 REST OF EUROPE: MESOTHERAPY MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 54 REST OF EUROPE: MESOTHERAPY MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 55 REST OF EUROPE: MESOTHERAPY MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 56 ASIA-PACIFIC: MESOTHERAPY MARKET, BY COUNTRY, 2019-2030 (USD MILLION)
  • TABLE 57 ASIA-PACIFIC: MESOTHERAPY MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 58 ASIA-PACIFIC: MESOTHERAPY MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 59 ASIA-PACIFIC: MESOTHERAPY MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 60 CHINA: MESOTHERAPY MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 61 CHINA: MESOTHERAPY MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 62 CHINA: MESOTHERAPY MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 63 JAPAN: MESOTHERAPY MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 64 JAPAN: MESOTHERAPY MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 65 JAPAN: MESOTHERAPY MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 66 INDIA: MESOTHERAPY MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 67 INDIA: MESOTHERAPY MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 68 INDIA: MESOTHERAPY MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 69 SOUTH KOREA: MESOTHERAPY MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 70 SOUTH KOREA: MESOTHERAPY MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 71 SOUTH KOREA: MESOTHERAPY MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 72 AUSTRALIA: MESOTHERAPY MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 73 AUSTRALIA: MESOTHERAPY MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 74 AUSTRALIA: MESOTHERAPY MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 75 REST OF ASIA PACIFIC: MESOTHERAPY MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 76 REST OF ASIA PACIFIC: MESOTHERAPY MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 77 REST OF ASIA PACIFIC: MESOTHERAPY MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 78 REST OF THE WORLD: MESOTHERAPY MARKET, BY COUNTRY, 2019-2030 (USD MILLION)
  • TABLE 79 REST OF THE WORLD: MESOTHERAPY MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 80 REST OF THE WORLD: MESOTHERAPY MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 81 REST OF THE WORLD: MESOTHERAPY MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 82 MIDDLE EAST: MESOTHERAPY MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 83 MIDDLE EAST: MESOTHERAPY MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 84 MIDDLE EAST: MESOTHERAPY MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 85 AFRICA: MESOTHERAPY MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 86 AFRICA: MESOTHERAPY MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 87 AFRICA: MESOTHERAPY MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 88 LATIN AMERICA: MESOTHERAPY MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 89 LATIN AMERICA: MESOTHERAPY MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
  • TABLE 90 LATIN AMERICA: MESOTHERAPY MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 91 MAJOR PLAYERS IN THE GLOBAL MESOTHERAPY MARKET
  • TABLE 92 MOST ACTIVE PLAYER IN THE GLOBAL MESOTHERAPY MARKET
  • TABLE 93 PRODUCT APPROVAL AND LAUNCH: GLOBAL MESOTHERAPY MARKET
  • TABLE 94 FILORGA: PRODUCTS OFFERED
  • TABLE 95 MESOSKINLINE: PRODUCTS OFFERED
  • TABLE 96 KORU PHARMACEUTICALS CO., LTD.: PRODUCTS OFFERED
  • TABLE 97 FUSION MESO: PRODUCTS OFFERED
  • TABLE 98 TOSKANI COSMETICS: PRODUCTS OFFERED
  • TABLE 99 ABBVIE INC.: PRODUCTS OFFERED
  • TABLE 100 GALDERMA LABORATORIES, L.P: PRODUCTS OFFERED
  • TABLE 101 GALDERMA LABORATORIES, L.P: KEY DEVELOPMENTS
  • TABLE 102 DERMOAROMA: PRODUCTS OFFERED
  • TABLE 103 MESSOESSENCE: PRODUCTS OFFERED
  • TABLE 104 INSTITUTE BCN: PRODUCTS OFFERED

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 GLOBAL MESOTHERAPY MARKET STRUCTURE
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
  • FIGURE 4 MARKET DYNAMICS OF GLOBAL MESOTHERAPY MARKET
  • FIGURE 5 DRIVERS IMPACT ANALYSIS: GLOBAL MESOTHERAPY MARKET
  • FIGURE 6 RESTRAINTS IMPACT ANALYSIS: GLOBAL MESOTHERAPY MARKET
  • FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL MESOTHERAPY MARKET
  • FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL MESOTHERAPY MARKET
  • FIGURE 9 GLOBAL MESOTHERAPY MARKET, BY PRODUCT, 2022 & 2030 (USD MILLION)
  • FIGURE 10 GLOBAL MESOTHERAPY MARKET, BY APPLICATION, 2022 & 2030 (USD MILLION)
  • FIGURE 11 GLOBAL MESOTHERAPY MARKET, BY END USER, 2022 & 2030 (USD MILLION)
  • FIGURE 12 GLOBAL: MESOTHERAPY MARKET, BY REGION 2022 & 2030 (USD MILLION)
  • FIGURE 13 GLOBAL: MESOTHERAPY MARKET SHARE (%), BY REGION 2022
  • FIGURE 14 NORTH AMERICA: MESOTHERAPY MARKET (%), BY COUNTRY, 2022
  • FIGURE 15 EUROPE: MESOTHERAPY MARKET SHARE (%), BY COUNTRY 2022
  • FIGURE 16 ASIA-PACIFIC: MESOTHERAPY MARKET SHARE (%), BY REGION, 2022
  • FIGURE 17 REST OF THE WORLD: MESOTHERAPY MARKET SHARE (%), BY REGION, 2022
  • FIGURE 18 BENCHMARKING OF MAJOR COMPETITORS
  • FIGURE 19 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL MESOTHERAPY MARKET
  • FIGURE 20 FILORGA: SWOT ANALYSIS
  • FIGURE 21 FUSION MESO: SWOT ANALYSIS
  • FIGURE 22 ABBVIE INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 23 ABBVIE INC.: SWOT ANALYSIS
  • FIGURE 24 GALDERMA LABORATORIES, L.P.: SWOT ANALYSIS
  • FIGURE 25 DERMOAROMA: SWOT ANALYSIS
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!